HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

AbstractOBJECTIVES:
To study the prospective relationship between serum levels of type II secretory phospholipase A2 (sPLA2) and the risk of future coronary artery disease (CAD) in apparently healthy men and women.
METHODS AND RESULTS:
We conducted a prospective nested case-control study among apparently healthy men and women aged 45 to 79 years. Cases (n=1105) were people in whom fatal or nonfatal CAD developed during follow-up. Controls (n=2209) were matched by age, sex, and enrollment time. sPLA2 levels were significantly higher in cases than controls (9.5 ng/mL; interquartile range [IQR], 6.4 to 14.8 versus 8.3 ng/mL; IQR, 5.8 to 12.6; P<0.0001). sPLA2 plasma levels significantly correlated with age, body mass index, systolic blood pressure, high-density lipoprotein (HDL) cholesterol levels, and C-reactive protein (CRP) levels. Taking into account matching for sex and age and adjusting for body mass index, smoking, diabetes, systolic blood pressure, low-density lipoprotein cholesterol, HDL cholesterol, and CRP levels, the risk of future CAD was 1.34 (1.02 to 1.71; P=0.02) for people in the highest sPLA2 quartile, compared with those in the lowest (P for linearity=0.03).
CONCLUSIONS:
Elevated levels of sPLA2 were associated with an increased risk of future CAD in apparently healthy individuals. The magnitude of the association was similar to that observed between CRP and CAD risk, and both associations were independent.
AuthorsS Matthijs Boekholdt, Tymen T Keller, Nicholas J Wareham, Robert Luben, Sheila A Bingham, Nicholas E Day, Manjinder S Sandhu, J Wouter Jukema, John J P Kastelein, C Erik Hack, Kay-Tee Khaw
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 25 Issue 4 Pg. 839-46 (Apr 2005) ISSN: 1524-4636 [Electronic] United States
PMID15692105 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Phospholipases A
  • Group II Phospholipases A2
  • Phospholipases A2
Topics
  • Aged
  • Biomarkers
  • Case-Control Studies
  • Coronary Artery Disease (blood, epidemiology)
  • Female
  • Follow-Up Studies
  • Group II Phospholipases A2
  • Humans
  • Male
  • Middle Aged
  • Phospholipases A (blood)
  • Phospholipases A2
  • Prospective Studies
  • Risk Factors
  • Sex Distribution
  • United Kingdom (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: